Post-earnings recap
Reported
Thu, Apr 26, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's strong EPS performance indicates effective cost management and operational efficiency. The stock's slight increase reflects investor confidence in the company's direction, despite the lack of revenue data and guidance. The positive surprise in EPS suggests that the company is navigating its market well, which may bode well for future quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.92 | N/A | +6.86% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized the importance of patient outcomes in their strategy.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and improving patient outcomes.